We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Text Messaging for Adherence in Adolescent Liver Transplant Recipients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01696331
Recruitment Status : Unknown
Verified November 2015 by Rebecca Berquist McKenzie, Stanford University.
Recruitment status was:  Active, not recruiting
First Posted : October 1, 2012
Last Update Posted : November 26, 2015
Information provided by (Responsible Party):

Study Description
Brief Summary:
Text message reminders will improve adherence to lab tests in adolescent liver transplant recipients.

Condition or disease Intervention/treatment
Liver Transplant Adherence Behavioral: Text Message Reminder

Detailed Description:
Adolescent patients who received a liver transplant will be recruited to participate in receiving text message reminders for lab tests. They will be send de-identified messages according to their required lab schedule. The investigators will monitor their adherence to lab tests as well as medication and clinic visits. They will also have a questionnaire about their medical regimen before and at the end of the study.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 42 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Impact of Text Messaging on Adherence in Adolescent Liver Transplant Patients
Study Start Date : September 2012
Primary Completion Date : January 2013
Estimated Study Completion Date : December 2016

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Text Message Reminder Behavioral: Text Message Reminder
Sent TM reminder at beginning and end of each month that corresponded to required lab frequency. Patients were able to send autoresponses.

Outcome Measures

Primary Outcome Measures :
  1. Adherence to lab tests [ Time Frame: One year ]

Secondary Outcome Measures :
  1. Texting responses [ Time Frame: 1 year ]
    Correspondence between actual completion of tests versus reported

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   12 Years to 25 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient >12 years
  • Received liver transplant
  • Followed by Stanford Liver Transplant Team

Exclusion Criteria:

  • No personal cell phone
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01696331

United States, California
Lucile Packard Children's Hospital
Palo Alto, California, United States, 94304
Sponsors and Collaborators
Stanford University
More Information

Responsible Party: Rebecca Berquist McKenzie, Clinical Instructor, Department of Pediatric Gastroenterology, Stanford University
ClinicalTrials.gov Identifier: NCT01696331     History of Changes
Other Study ID Numbers: 25318
First Posted: October 1, 2012    Key Record Dates
Last Update Posted: November 26, 2015
Last Verified: November 2015